PTH
·NASDAQ
--
--(--)
--
--(--)
Key Stats
Assets Under Management
130.91MUSD
Fund Flows (1Y)
-19.89MUSD
Dividend Yield
--
Discount/Premium to NAV
-0.02%
Shares Outstanding
2.52M
Expense Ratio
0.60%
About Invesco Dorsey Wright Healthcare Momentum ETF
Issuer
Invesco Capital Management LLC
Brand
Invesco
Inception Date
Oct 12, 2006
Structure
Open-Ended Fund
Index Tracked
Dorsey Wright Healthcare Technical Leaders Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
Invesco Capital Management LLC
Distributor
Invesco Distributors, Inc.
PTH provides an alternate take on US healthcare firms, with a lot of emphasis on the biotech and research sector compared to our more pharma and provider-focused neutral benchmark. PTH has been around for a while, but changed indexes in 2014 to adopt a momentum-weighted Dorsey-Wright relative strength index. This has contributed to the fund's sharp pivot away from neutral segment exposure toward growth sectors. Unsurprisingly, the fund tilts small, and carries considerably more risk. The fund selects the top, at least 30 stocks, with the highest momentum scores in the healthcare space. The fund uses a full replication indexing strategy, meaning PTH will generally invest in all of the stocks of the underlying index and in proportion to the weightings. Overall, PTH offers a different, growth-focused take on healthcare. Investors should consider all-in costs of holding the fund. The fund is reconstituted and rebalanced quarterly. Prior to August 28, 2023, the ETF's name was Invesco DWA Healthcare Momentum ETF.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Broad-based
Strategy
Momentum
Geography
U.S.
Weighting Scheme
Momentum
Selection Criteria
Momentum
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | +4.36% | +30.50% | +28.88% | +24.82% | +25.71% | -1.81% |
NAV Total Return | +6.89% | +29.15% | +28.60% | +21.07% | +25.91% | -0.35% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
98.82%
1.18%
Category
Ratio
North America
98.82%
Europe
1.18%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Growth
Comprises companies of multiple sizes that have high growth potential. These ETFs focus on firms across different market caps with promising growth prospects.
Top 10 Holdings
Symbol
Ratio
CDTX
Cidara Therapeutics
6.51%
INSM
Insmed
4.87%
MEDP
Medpace Holdings
4.52%
GH
Guardant Health
4.35%
NTRA
Natera
3.78%
CELC
Celcuity
3.69%
THC
Tenet
3.21%
NKTR
Nektar Therapeutics
3.02%
BSX
Boston Scientific
2.97%
MDGL
Madrigal
2.93%
Top 10 Weight 39.85%
58 Total Holdings
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2024-06-24 | 2024-06-24 | 2024-06-28 | 0.025 |
Premium/Discount Chart
Premium/Discount to NAV
Price
1M
Assets Under Management
Assets Under Management
1M
Fund Flows
Inflows
Outflows
1M
